With EXCITE International’s collaborative approach, customized clinical trial protocols are designed with input from international payers, health systems, the scientific community, as well as expert end-users, patients, and other relevant key stakeholders.
The expectations of regulators and input from usability and human factor experts are also incorporated into our clinical trial protocols. Doing so ensures that evidence relevant to key decision-makers is identified in the pre-market space. EXCITE International then develops and executes a protocol which is intended to meet the evidence needs of the key pre-and post-market decision-makers.
Our world-class methodological centres and clinical trial networks are used to implement the inclusive protocol to collect, analyze, and synthesize data for both regulatory and adoption purposes – our benchmark for success. The EXCITE International network collaborates with their local key stakeholders to select, evaluate, and adopt impactful technologies through their role as an EXCITE International partner. Oversight of each clinical trial is provided by designated credible Clinical Research Organizations and health system clinical trial networks.
This unique collaborative approach recognizes the importance of engaging key stakeholders early on to improve the likelihood of adoption. It provides evidence needed to support health planning based on demonstrating that the technology improves the net health outcome for the indicated patient population. In so doing, this approach reduces the need for additional studies at the point of decision-making regarding coverage/payment and adoption.
Through the synchronous involvement of multiple stakeholders in EXCITE member countries, EXCITE International accelerates the pathway of high-impact technologies to patients and health systems worldwide.
EXCITE International cannot guarantee the final adoption of any technology as such decisions falls under the purview and unique policies, legal, and legislative requirements of each payer and health system.